A simplified snapshot as of mid-2026: FDA-approved (legal by prescription): semaglutide and tirzepatide (GLP-1 medications for weight and metabolic health) and tesamorelin
Giorgio Roberto Merlo, University of Turin, Italy Updates Copyright 2021 Desole, Gallo, Vitacolonna, Montarolo, Bertolotto, Vivien, Comoglio and Crepaldi
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-met, in experimental models of anaplastic large-cell lymphoma
doi: 10.1089/ast.2017.1812, 48 KallistovaA.MerkelA.KanapatskiyT.BoltyanskayaY.TarnovetskiiI.PerevalovaA.et al
On August 13, 2025, CMS released updated CMS Medicare Part B vaccine payment allowance limits for the 2025 to 2026 influenza season, effective August 1, 2025, through July 31, 2026
Ongoing investigations continue to examine the peptides mechanisms of action and potential therapeutic applications, though definitive conclusions about its clinical benefits require additional research